Product Name: KinSubaRRKSF
Product Number: PE-01ALS95
Size: 200 µg      Price:99.00
      $US
Peptide Name: KinSubaRRKSF

Product Use: For assaying the phosphotransferase activity of Homeodomain-interacting protein kinase 4 (HIPK4, UniProt ID Q8NE63). The KinSubaRRKSF peptide demonstrated very high phosphotransferase activity with CHK2, and exhibited very low specificity when assayed with over 200 other protein kinases. A listing of other kinases that show appreciable phosphotransferase activity towards this peptide are listed in Table 1.

Peptide Production Method: Solid-phase peptide synthesis

Peptide Origin: KinSubaRRKSF was originally identified using a microarray with peptides that were predicted as optimal substrates for 500 human protein kinases with a proprietary algorithm developed at Kinexus with our academic partners.

Peptide Sequence: GGRGRRKSFRRIGHG

Peptide Modifications N Terminus: Free amino

Peptide Modifications C Terminus: Amide

Peptide Molecular Mass Calculated: 1696 Da

Peptide Purity Percent after Synthesis and Purification: >95

Peptide Appearance: White powder

Peptide Form: Solid

Storage Conditions: -20°C

Peptide Recommended Enzyme: CHK2

Scientific Background: HIPK4 is one of several protein kinases that can phosphorylate KinSubaRRKSF. Human HIPK4 is a protein-serine/threonine kinase of 616 amino acid length, with a predicted molecular mass of 69,425 Da. It is a member of the CMGC group of protein kinases in the DYRK family, and HIPK subfamily. Orthologues of HIPK4 are highly conserved in mammals. HIPK4 can act as a co-repressor of transcription factors (1). HIPK4 has been shown to phosphorylate the human p53 protein at S9, both in vitro and in vivo which is important for p53 mediated transcriptional repression. RT-PCR analysis showed moderate expression of HIPK4 in lung and white adipose tissue and weak expression in brain and liver. HIPK4 expression has also been observed in various cancer cell lines (2).